British Society for Haematology guideline on early diagnosis of AL amyloidosis across haematology, cardiology, neurology, renal and general clinics: early-stage disease has about 80% 5-year survival versus under 30% for advanced disease.
Guideline
Garg et al. Early diagnosis of AL amyloidosis in haematology, cardiology, neurology, renal and general clinics: A British Society for Haematology Guideline